Literature DB >> 10723576

Stem cell transplantation for treatment of severe autoimmune diseases: current status and future perspectives.

E Jantunen1, R Myllykangas-Luosujärvi.   

Abstract

Autoimmune diseases include a heterogeneous group of disorders with variable presentation and severity. Immunosuppressive and immunomodulatory therapies are often used for treatment with considerable success in some cases. These diseases may also be severe and refractory to conventional treatment. Thus more aggressive intervention might be indicated in a subset of patients. Animal studies suggest that high-dose therapy supported by stem cell transplantation may lead to remissions in experimental autoimmune disease models. Anecdotal case reports suggest that the same may be the case in some human autoimmune diseases as well. This review attempts to summarise some current concepts and future perspectives on stem cell transplantation in the treatment of severe autoimmune diseases.

Entities:  

Mesh:

Year:  2000        PMID: 10723576     DOI: 10.1038/sj.bmt.1702152

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.

Authors:  D Farge; J Passweg; J M van Laar; Z Marjanovic; C Besenthal; J Finke; H H Peter; F C Breedveld; W E Fibbe; C Black; C Denton; I Koetter; F Locatelli; A Martini; A V N Schattenberg; F van den Hoogen; L van de Putte; F Lanza; R Arnold; P A Bacon; S Bingham; F Ciceri; B Didier; J L Diez-Martin; P Emery; W Feremans; B Hertenstein; F Hiepe; R Luosujärvi; A Leon Lara; A Marmont; A M Martinez; H Pascual Cascon; C Bocelli-Tyndall; E Gluckman; A Gratwohl; A Tyndall
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

Review 2.  Treatment options for juvenile-onset systemic lupus erythematosus.

Authors:  Luis Carreño; Francisco Javier López-Longo; Carlos Manuel González; Indalecio Monteagudo
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Autologous hematopoietic stem cell transplantation for 3 patients with severe juvenile rheumatoid arthritis.

Authors:  Tomoko Kishimoto; Takashi Hamazaki; Masahiro Yasui; Makoto Sasabe; Takayuki Okamura; Naoki Sakata; Masami Inoue; Keiko Yagi; Keisei Kawa
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

4.  Mesenchymal stem cell transplantation can restore lupus disease-associated miRNA expression and Th1/Th2 ratios in a murine model of SLE.

Authors:  Eun Wha Choi; MinJae Lee; Ji Woo Song; Il Seob Shin; Sung Joo Kim
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.